Using innovative computer-based approaches, researchers have developed protein inhibitors that block the interaction between the SARS-CoV-2 virus and human cell receptor ACE2. In cell culture, the most potent of these inhibitors could neutralize virus infection, paving the way for their use in therapies that could be delivered more easily than antibodies.
SARS-CoV-2 infection generally begins in the nasal cavity. The monoclonal antibodies in development as treatments for COVID-19 are not ideal for intranasal delivery, however, as antibodies are large and often not extremely stable.
Small proteins that bind tightly to the SARS-CoV-2 spike and block the interaction with the human cellular receptor ACE2 may allow direct delivery through intranasal administration. Previous work in rodents has shown that intranasal delivery of small proteins designed to bind tightly to an influenza protein could provide protection against infection.
Here, using novel approaches to identify new, higher-affinity binding modes with the SARS-CoV-2 spike's receptor binding domain (RBD), the authors developed a series of inhibitors - optimized in their amino acid sequences for targeted binding, folding and stability - that bound to distinct regions of the RBD surface surrounding the ACE2 binding site.
When they evaluated their inhibitors in cell culture, several bound with particularly high affinities to SARS-CoV-2 and two neutralized the virus, preventing infection. The small proteins were stable after 14 days at room temperature, addressing concerns associated with cold storage needs required for some antibodies and vaccine candidates.
These "minibinders" provide starting points for SARS-CoV-2 therapeutics, the authors say. After further development, they could be used in a gel for nasal application, or for direct delivery into the respiratory system by nebulization.
"We will be exploring alternative routes of delivery in the months ahead as we seek to translate the high potency neutralizing proteins into SARS-CoV-2 therapeutics and prophylactics," they write. They also address the utility of their computational design-based approach for preparing against future pandemics.
https://science.sciencemag.org/CONTENT/EARLY/2020/09/08/SCIENCE.ABD9909
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fde-novo-design-of&filter=22
Mini proteins to treat COVID-19
- 1,366 views
- Added
Edited
Latest News
A new gene-editing system
By newseditor
Posted 23 May
How ketamine's molecular ac…
By newseditor
Posted 23 May
Therapeutic avenues in bone…
By newseditor
Posted 23 May
Linking key nutrients with…
By newseditor
Posted 23 May
Ferroptosis in fatal COVID-…
By newseditor
Posted 22 May
Other Top Stories
Plasma treatment for strong adhesion without adhesives
Read more
"Scavenger" Molecule Prevents Nerve Agent Poisoning in Animals
Read more
Social interactions reduce feeding behavior!
Read more
Mosquitoes can hear up to 10 meters away
Read more
Brain's response to texture
Read more
Protocols
Efficient expansion and CRI…
By newseditor
Posted 21 May
Massively parallel in vivo…
By newseditor
Posted 20 May
Breast cancer-on-chip for p…
By newseditor
Posted 16 May
Methods for making and obse…
By newseditor
Posted 15 May
Mime-seq 2.0: a method to s…
By newseditor
Posted 13 May
Publications
Patterning and folding of i…
By newseditor
Posted 23 May
Peri-ictal activation of do…
By newseditor
Posted 23 May
Ancestry, ethnicity, and ra…
By newseditor
Posted 23 May
Ketamine can produce oscill…
By newseditor
Posted 23 May
Upregulation of neuronal ER…
By newseditor
Posted 23 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar